China – Chinese regulators delay medical device UDI implementation

China’s National Medical Products Administration (NMPA) has extended the trial period for its medical device unique device identification (UDI) program in response to the coronavirus pandemic, pushing first-round UDI implementation requirement deadlines to early 2021.

The NMPA announced (link in Chinese) that the impact of the COVID-19 public health emergency in China has necessitated pushing back the regulator’s UDI trial period ending date from October 1, 2020 to January 1 2021…